$MRK - stock is close to flag breakout hereMRK - Stock flagging on the daily time frame holding just below $112 resistance level. looking for a breakout move here above $112 for a move towards $115 and $120. Stock is strong at the indicator level.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
18.25 B USD
65.01 B USD
2.48 B
About Merck & Company, Inc.
Sector
Industry
CEO
Robert M. Davis
Website
Headquarters
Rahway
Founded
1891
IPO date
Jan 1, 1941
Identifiers
3
ISIN US58933Y1055
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.
Related stocks
Swing Long on Merck & CoI'm going long here on this healthcare company. Looking good for a rebound soon.
MERCK_1W_BuyWe buy MERCK shares with the main support of 97 and the target of 157 with a growth of 37 to 57 percent.
Live trading on MRK stock.We enter Wave 5 in the demand zone.
NYSE:MRK
Wave 4 done
We have two profit-taking zones.
Follow proper risk and money management.
MRK - Bear signal bell!=======
Volume
=======
-neutral
==========
Price Action
==========
- Bearish flag noticed
- Weak buying pressure after price gap up
=================
Technical Indicators
=================
- Ichimoku
>>> price above cloud
>>> Green kumo thinning
>>> Tenken + Chiku - above clouds and towards
>
MRK 1H Conservative Short SwingTradeConservative Trade
+ short impulse
+ 1/2 correction
+ BUI test level (exhaustion volume?)
+ weak approach
+ biggest volume Ut?
+ weak test
+ first bearish bar close entry
Calculated affordable virtual stop
(bought puts)
1 to 2 R/R take profit
1D Trend
"+ short impulse
+ short volume distribution
Merck & Co.(NYSE: $MRK): FDA Approvals & Key Rejection Zone TestMerck & Co. (NYSE: NYSE:MRK ) traded lower at $101.53 after receiving conditional FDA approval for two new cattle antiparasitic treatments—Exzolt Cattle-CA1 and Dectomax-CA1. The approvals target rising cases of New World screwworm larvae and fever ticks, two livestock threats that the FDA says cou
MRkStock: Merck & Company (MRK) – NYSE
Timeframe: 1H (short–to–mid term outlook)
Current Situation
The stock is trading around 85.16 – 85.33.
It has broken out of a long descending channel (yellow zone), signaling a potential trend reversal to the upside.
Suggested entry on the chart: Buy at 84.80
Merck (NYSE: $MRK) Wins EU Approval for Subcutaneous KeytrudaMerck (NYSE: NYSE:MRK ) has secured a major regulatory milestone after the European Commission approved a new subcutaneous version of Keytruda, the company’s flagship cancer therapy. This marks a significant expansion for one of the world’s best-selling immunotherapy drugs, previously only administ
My Take on MRK (Merck & Co.)After a year of falling prices, MRK looks ready to stage a recovery. The stock is now testing the upper range of its consolidation zone — a potential breakout could open the path back toward previous highs.
With strong fundamentals and stellar earnings this year, I’ll be watching closely for a conf
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
MRK6249696
Merck & Co., Inc. 5.7% 04-DEC-2065Yield to maturity
5.78%
Maturity date
Dec 4, 2065
MRK5584756
Merck & Co., Inc. 5.15% 17-MAY-2063Yield to maturity
5.70%
Maturity date
May 17, 2063
MRK6249695
Merck & Co., Inc. 5.55% 04-DEC-2055Yield to maturity
5.65%
Maturity date
Dec 4, 2055
MRK6166087
Merck & Co., Inc. 5.7% 15-SEP-2055Yield to maturity
5.64%
Maturity date
Sep 15, 2055
MRK5319197
Merck & Co., Inc. 2.9% 10-DEC-2061Yield to maturity
5.64%
Maturity date
Dec 10, 2061
MRK5584755
Merck & Co., Inc. 5.0% 17-MAY-2053Yield to maturity
5.58%
Maturity date
May 17, 2053
MRK4806294
Merck & Co., Inc. 4.0% 07-MAR-2049Yield to maturity
5.55%
Maturity date
Mar 7, 2049
MRK5319196
Merck & Co., Inc. 2.75% 10-DEC-2051Yield to maturity
5.55%
Maturity date
Dec 10, 2051
MRK5002693
Merck & Co., Inc. 2.45% 24-JUN-2050Yield to maturity
5.52%
Maturity date
Jun 24, 2050
MRK6249694
Merck & Co., Inc. 5.5% 15-MAR-2046Yield to maturity
5.50%
Maturity date
Mar 15, 2046
US58933YAT29
Merck & Co., Inc. 3.7% 10-FEB-2045Yield to maturity
5.43%
Maturity date
Feb 10, 2045
See all MRK bonds
Frequently Asked Questions
The current price of MRK is 121.93 USD — it has increased by 1.82% in the past 24 hours. Watch Merck & Company, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Merck & Company, Inc. stocks are traded under the ticker MRK.
MRK stock has risen by 12.28% compared to the previous week, the month change is a 11.35% rise, over the last year Merck & Company, Inc. has showed a 36.37% increase.
We've gathered analysts' opinions on Merck & Company, Inc. future price: according to them, MRK price has a max estimate of 140.00 USD and a min estimate of 86.00 USD. Watch MRK chart and read a more detailed Merck & Company, Inc. stock forecast: see what analysts think of Merck & Company, Inc. and suggest that you do with its stocks.
MRK stock is 2.42% volatile and has beta coefficient of 0.54. Track Merck & Company, Inc. stock price on the chart and check out the list of the most volatile stocks — is Merck & Company, Inc. there?
Today Merck & Company, Inc. has the market capitalization of 302.63 B, it has increased by 0.15% over the last week.
Yes, you can track Merck & Company, Inc. financials in yearly and quarterly reports right on TradingView.
Merck & Company, Inc. is going to release the next earnings report on Apr 30, 2026. Keep track of upcoming events with our Earnings Calendar.
MRK earnings for the last quarter are 2.04 USD per share, whereas the estimation was 2.01 USD resulting in a 1.43% surprise. The estimated earnings for the next quarter are −1.50 USD per share. See more details about Merck & Company, Inc. earnings.
Merck & Company, Inc. revenue for the last quarter amounts to 16.40 B USD, despite the estimated figure of 16.20 B USD. In the next quarter, revenue is expected to reach 15.95 B USD.
MRK net income for the last quarter is 2.96 B USD, while the quarter before that showed 5.79 B USD of net income which accounts for −48.78% change. Track more Merck & Company, Inc. financial stats to get the full picture.
Yes, MRK dividends are paid quarterly. The last dividend per share was 0.85 USD. As of today, Dividend Yield (TTM)% is 2.69%. Tracking Merck & Company, Inc. dividends might help you take more informed decisions.
Merck & Company, Inc. dividend yield was 3.12% in 2025, and payout ratio reached 45.05%. The year before the numbers were 3.14% and 46.32% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, MRK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Merck & Company, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Merck & Company, Inc. technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Merck & Company, Inc. stock shows the strong buy signal. See more of Merck & Company, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.